In conclusion, systemic inflammation levels are significantly associated with hepatic steatosis and NAFLD risk, with CRP having the strongest correlation and composite systemic inflammatory indicators being more strongly correlated than any individual blood cell count variable. This evidence concerns the gene CRP and fatty liver disease.